Vitiligo

What vitiligo is

Melanocytes are cells that produce pigment in skin and hair. In vitiligo, immune activity damages or destroys melanocytes in affected areas. Patches lose color and may become milky white. Hair within a patch can also turn white.

Vitiligo can affect any skin tone. Contrast may be more visible on darker skin, but the medical and emotional impact is individual. The condition is not contagious and does not result from dirt, infection, food, or a person’s character.

Nonsegmental vitiligo often affects both sides of the body and can change over time. Segmental vitiligo usually affects one region and often begins younger. These patterns help guide prognosis and treatment but are not assigned from one photo.

How pigment loss can appear

Patches may appear on hands, face, around body openings, feet, elbows, knees, genitals, or other sites. Mucous membranes and hair can be involved. New patches may appear after skin injury, friction, or sunburn in some people.

The edge can be clear or changing. Some people have areas of partial pigment loss rather than fully white skin. Progression may be rapid, slow, intermittent, or stable for years.

Fungal infection, post-inflammatory change, chemical exposure, scars, genetic conditions, and other disorders can cause lighter skin. Vitiligo should not be diagnosed solely because a patch looks pale in a photograph.

When to seek prompt care

Vitiligo itself is not usually an emergency. Prompt assessment is appropriate for sudden widespread pigment loss, severe skin inflammation, eye pain or vision change, or signs of another autoimmune condition.

Use urgent or emergency care for serious eye pain with vision loss, breathing difficulty, collapse, severe weakness, or another acute problem. Do not attribute every symptom to vitiligo.

Depression, bullying, social withdrawal, or thoughts of self-harm deserve direct support. Use crisis or emergency services for immediate danger. Psychological impact is a legitimate health concern, not vanity.

How clinicians diagnose vitiligo

A clinician reviews onset, progression, family history, other autoimmune conditions, medicines, chemical exposures, prior rashes, and symptoms. Examination includes the skin, hair, nails, and sometimes mouth or genital areas with consent.

A Wood’s lamp uses ultraviolet light to highlight depigmented areas and help distinguish vitiligo from some look-alikes. It is an examination tool, not a tanning device or home test. Results still require clinical interpretation.

Blood tests may be considered when symptoms or history suggest thyroid disease or another autoimmune condition. Routine broad autoimmune panels are not necessary for everyone. A biopsy is uncommon but can help when the diagnosis is uncertain.

Standardized photographs and body maps can monitor change. Lighting, camera settings, season, and tanning of surrounding skin can alter appearance, so comparisons need consistency.

Autoimmune and family context

Vitiligo can occur with thyroid disease, type 1 diabetes, pernicious anemia, Addison disease, rheumatoid arthritis, lupus, psoriasis, and other autoimmune conditions. Association does not mean every person has or will develop them.

Family history and genes influence risk, but inheritance is complex. A parent with vitiligo cannot predict whether a child will develop it. Genetic testing is not routinely used to diagnose ordinary vitiligo.

Symptoms such as weight change, heat or cold intolerance, unusual fatigue, thirst, urination changes, weakness, or joint problems should be discussed on their own merits rather than prompting repeated unsupervised testing.

Treatment goals and choices

Treatment goals can include slowing active spread, restoring pigment, making color more even, protecting sensitive skin, or improving confidence. Not every person wants active repigmentation, and no one should be pressured to change their appearance.

Topical medicines can reduce local immune activity and encourage repigmentation. Choice depends on age, body site, patch size, activity, skin thickness, pregnancy, and risk of side effects. Potent products used on the face or folds without supervision can damage skin.

Phototherapy uses controlled ultraviolet exposure and can treat broader areas. Sessions are repeated over time, and response differs by body site. Medical phototherapy is not the same as a tanning bed or deliberate sunburn.

Targeted light can treat smaller areas. Surgical grafting or cell-transfer procedures may be considered for stable disease that has not responded to other care. Surgery is less suitable when vitiligo is actively spreading or when a person tends to form keloids.

Depigmentation of remaining pigmented skin is a major, usually permanent decision considered only in selected extensive cases. It increases lifelong sun sensitivity and requires careful counseling.

What treatment can and cannot do

Repigmentation often takes months and may be incomplete or uneven. Face and trunk may respond differently from fingers or feet. New patches can develop while treated areas improve, and color can be lost again after treatment stops.

A lack of response is not a personal failure. Adherence can be affected by cost, access, time, skin irritation, work, caregiving, and the burden of repeated visits. The plan should match the person’s priorities and resources.

Products marketed as cures, detoxes, immune boosters, or pigment restorers can contain steroids, heavy metals, or undisclosed ingredients. Supplements can interact with medicines and have not been shown to cure vitiligo.

Sun protection and skin care

Depigmented skin burns more easily. Broad-spectrum sunscreen, protective clothing, shade, and avoiding deliberate tanning can reduce burns and contrast. Sunscreen should be chosen for skin type, allergies, activities, and access.

Self-tanners, cosmetics, dyes, micropigmentation, or clothing can camouflage patches if desired. These are personal choices, not requirements. Patch-test products and ask about ingredients that can irritate or trigger contact dermatitis.

Treat cuts, burns, and friction gently. Avoid bleaching agents and harsh home remedies. A new rash within or around vitiligo may be a separate condition and deserves assessment.

Children, pregnancy, and daily life

Children need diagnosis confirmed because several childhood pigment conditions resemble vitiligo. Treatment considers age, school routine, growth, body site, and the child’s own preferences. Adults should address bullying and avoid framing the child as damaged.

Pregnancy and breastfeeding change the safety of some topical and systemic treatments. Review the plan before conception when possible. Do not stop a necessary medicine abruptly without guidance.

Work, relationships, cultural beliefs, and discrimination shape impact. Support groups and counseling can help, but the person should decide when and how to discuss the condition.

Preparing for dermatology care

Bring photos showing change, family and autoimmune history, medicines, chemical exposure, prior rashes, symptoms, pregnancy plans, and treatments tried. Note whether patches are spreading and which areas matter most to you.

Ask what supports the diagnosis, whether testing is needed, whether disease appears active, and what outcomes are realistic for each site. Discuss time, cost, side effects, maintenance, sun protection, and the choice not to pursue repigmentation.

Distinguishing vitiligo from other pigment change

Not every pale patch is vitiligo. Fungal infection, inflammation, injury, chemical exposure, congenital pigment patterns, medication effects, and other skin conditions can reduce color. Some cause scaling, itch, altered sensation, or a pattern unlike vitiligo. Self-treatment with antifungal, steroid, bleaching, or combination creams can change the appearance and make diagnosis harder.

A dermatologist considers the border, distribution, hair color, surface texture, timing, symptoms, and related findings. A Wood lamp can make pigment loss easier to see, particularly in lighter skin, but it is interpreted with the examination. A skin sample or blood test is reserved for specific uncertainty or associated concerns rather than required for every person.

Seek prompt review if pigment change occurs with pain, blistering, a rapidly spreading rash, weakness, numbness, eye symptoms, or systemic illness. A changing mole, bleeding lesion, or nonhealing sore is assessed on its own and should not be attributed to vitiligo.

Tracking activity and judging treatment

Standardized photographs taken in similar lighting and position can show whether patches are expanding, stabilizing, or repigmenting. Avoid frequent close inspection under different lighting because normal variation can be misleading. A dermatologist may also look for new small spots, changes at sites of friction or injury, and signs that treatment is working around hair follicles.

Response differs by body site. The face and neck often respond better than hands, feet, lips, or areas with white hair because hair follicles can provide pigment-producing cells. Treatment usually takes months, and color can be incomplete or lost again. Agree on a review point, meaningful outcome, and stopping rule before committing substantial time and cost.

Repigmentation is not the only valid goal. Preventing spread, reducing contrast, protecting skin, using camouflage, receiving psychological support, or choosing no active treatment can all be reasonable. Claims of a guaranteed cure, rapid permanent repigmentation, or treatment through undisclosed mixtures should be treated cautiously.

Common questions

Is vitiligo contagious?

No. It cannot be spread by touch, sharing objects, swimming, food, or sex.

Does vitiligo mean skin cancer?

No. Vitiligo is not skin cancer. Depigmented skin needs sun protection, and any changing mole, bleeding lesion, or nonhealing sore should be assessed separately.

Can stress cause vitiligo?

Stress may coincide with change for some people, but vitiligo is an autoimmune condition with genetic and environmental influences. Blaming stress alone can delay appropriate care.